Literature DB >> 30317412

Analyzing the impact of systems-based hematologist in the healthcare system at an academic medical center.

Ming Y Lim1, Charles S Greenberg2.   

Abstract

Over the next decade, there is a predicted shortage of nonmalignant hematologist to maintain the workforce in the United States. To address this, the American Society of Hematology described the creation of the healthcare systems-based hematologist (SBH). The role of SBH has the potential to provide high-value, cost-conscious care to the healthcare system. In 2011, an Anticoagulation and Bleeding Management Medical Directorship position for a SBH was created at our healthcare system. We described our 6-year experience as SBH at a 750-bed tertiary academic medical center to improve clinical outcomes while reducing costs. Via four different initiatives, we were able to provide high-value, cost-conscious care as SBH by reducing cost of heparin-induced thrombocytopenia management, optimizing blood product utilization using goal-directed algorithms, reducing inappropriate thrombophilia testing and improving inferior vena cava filter retrieval rates. To ensure continuing success as a SBH, business plans need to include education, enforcement, monitoring, feedback, validation of safety and outcomes and a shared vision among leadership.

Entities:  

Keywords:  Cost savings; Healthcare system; Quality improvement

Mesh:

Year:  2019        PMID: 30317412     DOI: 10.1007/s11239-018-1756-5

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  8 in total

Review 1.  Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions.

Authors:  Indravadan J Patel; Jon C Davidson; Boris Nikolic; Gloria M Salazar; Marc S Schwartzberg; T Gregory Walker; Wael A Saad
Journal:  J Vasc Interv Radiol       Date:  2012-04-17       Impact factor: 3.464

2.  Initial and long term impact of a multi-disciplinary task force in the diagnosis and management of heparin-induced thrombocytopenia.

Authors:  Ming Y Lim; Joyce Foster; Angela Rourk; Charles S Greenberg
Journal:  J Thromb Thrombolysis       Date:  2018-01       Impact factor: 2.300

3.  The role of hematologists in a changing United States health care system.

Authors:  Paul J Wallace; Nathan T Connell; Janis L Abkowitz
Journal:  Blood       Date:  2015-03-06       Impact factor: 22.113

4.  Coagulopathy in cirrhosis: A prospective study to correlate conventional tests of coagulation and bleeding following invasive procedures in cirrhotics.

Authors:  Apurva Shah; Deepak Amarapurkar; Mrudul Dharod; Madhuri Chandnani; Rajiv Baijal; Praveen Kumar; Mayank Jain; Nikhil Patel; Praful Kamani; Sonali Gautam; Nimish Shah; Sandeep Kulkarni; Soham Doshi
Journal:  Indian J Gastroenterol       Date:  2015-09

5.  Activity-based costs of plasma transfusions in medical and surgical inpatients at a US hospital.

Authors:  A Shander; S Ozawa; A Hofmann
Journal:  Vox Sang       Date:  2016-02-25       Impact factor: 2.144

6.  Inpatient thrombophilia testing: Impact of healthcare system technology and targeted clinician education on changing practice patterns.

Authors:  Ming Y Lim; Charles S Greenberg
Journal:  Vasc Med       Date:  2017-11-20       Impact factor: 3.239

7.  Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: A randomized, controlled trial.

Authors:  Lesley De Pietri; Marcello Bianchini; Roberto Montalti; Nicola De Maria; Tommaso Di Maira; Bruno Begliomini; Giorgio Enrico Gerunda; Fabrizio di Benedetto; Guadalupe Garcia-Tsao; Erica Villa
Journal:  Hepatology       Date:  2015-12-09       Impact factor: 17.425

8.  Evaluation of heparin-induced thrombocytopenia (HIT) laboratory testing and the 4Ts scoring system in the intensive care unit.

Authors:  Wesly Pierce; Joseph Mazur; Charles Greenberg; Joan Mueller; Joyce Foster; John Lazarchick
Journal:  Ann Clin Lab Sci       Date:  2013       Impact factor: 1.256

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.